University of Leicester
Browse
Dietary+Supplementation+for+the+Prevention+and_FINAL.pdf (385.08 kB)

Nutritional Supplementation for the Prevention and/or Treatment of Gestational Diabetes Mellitus.

Download (385.08 kB)
journal contribution
posted on 2019-08-07, 13:20 authored by JF Plows, CM Reynolds, MH Vickers, PN Baker, JL Stanley
PURPOSE OF REVIEW: Gestational diabetes mellitus (GDM) is a common pregnancy complication that has short- and long-term health implications for both the mother and child. While lifestyle modifications, insulin therapy, and oral agents such as metformin are effective, they can be difficult to adhere to, and there remain concerns over long-term effects of oral agents on the infant. Further, GDM has no proven preventive strategies, which could be more effective than treatment postdiagnosis. Nutritional supplements are an appealing, potentially safer, and better tolerated alternative to pharmaceuticals to treat and/or prevent GDM. Here, we review the existing evidence for nutritional supplementation for treatment and prevention of GDM. RECENT FINDINGS: There is limited evidence that myo-inositol, vitamins D and B6, magnesium, selenium, zinc, fatty acids, and probiotics might be beneficial for the prevention or treatment of GDM. There are very few studies for each nutrient, and the existing studies tend to have few participants. Where multiple studies of a nutrient exist, often those studies were conducted within the same country, limiting the generalizability of the findings, or alternatively there was no consensus across findings. There is limited evidence that nutritional supplementation of myo-inositol, vitamins D and B6, magnesium, selenium, zinc, fatty acids, and probiotics could improve glycemic control or prevent GDM. Our understanding is constrained by the small number of studies, small sample sizes in most studies, and by lack of consistency across findings. Further large, high-quality, randomized controlled trials are required to determine the efficacy of nutritional supplements to treat or prevent GDM.

Funding

The authors received no financial support for this article. JP, MV, PB, and JS have previously received research funding from the Nestle Research Center (NRC).

History

Citation

Current Diabetes Reports, 2019, 19:73

Author affiliation

/Organisation/COLLEGE OF LIFE SCIENCES

Version

  • AM (Accepted Manuscript)

Published in

Current Diabetes Reports

Publisher

Springer (part of Springer Nature)

eissn

1539-0829

Copyright date

2019

Publisher version

https://link.springer.com/article/10.1007/s11892-019-1199-1

Notes

The file associated with this record is under embargo until 12 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.

Language

en

Usage metrics

    University of Leicester Publications

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC